Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Genetic Polymorphisms of the RANKL and OPG Genes Associated with Myeloma

Gunter Assmann, Stefanie Keller, Mei Fang Ong, Sandra Grass, Michael Pfreundschuh, Stefan Wieczorek

Blood (2011) 118 (21): 2911.

https://doi.org/10.1182/blood.V118.21.2911.2911

Published: 2011

Journal Articles

New Insights in the Pathogenesis of MGUS, Multiple Myeloma (MM) and Waldenström`s Macroglobulinemia (WM): Chronic Antigenic Stimulation by Autoantigenic Targets of Paraproteins Is Mediated by CD4 + t-Cells

Sandra Grass, MD, Klaus-Dieter Preuss, Aleksandra Wikowicz, Natalie Fadle, Evi Regitz, Gerhard Held, Leon Bernal-Mizrachi, MD, Sybille Raudies, Holger Thiele, Michael Pfreundschuh, MD, Frank Neumann

Blood (2011) 118 (21): 472.

https://doi.org/10.1182/blood.V118.21.472.472

Published: 2011

Journal Articles

Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A

Klaus-Dieter Preuss, Michael Pfreundschuh, Natalie Fadle, Evi Regitz, Sybille Raudies, Niels Murwaski, Manfred Ahlgrimm, Joerg Bittenbring, Markus Klotz, Karl-Herbert Schäfer, Gerhard Held, Frank Neumann, Sandra Grass

Blood (2011) 118 (12): 3340–3346.

https://doi.org/10.1182/blood-2011-04-351668

Published: 2011

Journal Articles

Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM

Sandra Grass, Klaus-Dieter Preuss, Stephan Thome, Dennis D. Weisenburger, Vinetta Witt, Jane Lynch, Florian Zettl, Lorenz Trümper, Natalie Fadle, Evi Regitz, Henry Lynch, Michael Pfreundschuh

Blood (2011) 118 (3): 635–637.

https://doi.org/10.1182/blood-2011-01-331454

Published: 2011

Includes: Supplemental data

Journal Articles

Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenström macroglobulinemia

Sandra Grass, Klaus-Dieter Preuss, Alexandra Wikowicz, Evangelos Terpos, Marita Ziepert, Diana Nikolaus, Yin Yang, Natalie Fadle, Evi Regitz, Meletios A. Dimopoulos, Steven P. Treon, Zachary R. Hunter, Michael Pfreundschuh

Blood (2011) 117 (10): 2918–2923.

https://doi.org/10.1182/blood-2010-09-306076

Published: 2011

Includes: Supplemental data

Journal Articles

Hyperphosphorylation of Antigenic Targets of Paraproteins In MGUS and Multiple Myeloma (MM) Is a Consistent Finding: Implications for the Pathogenesis of MGUS/MM

Sandra Grass, MD, Klaus-Dieter Preuss, Aleksandra Wikowicz, Natalie Fadle, Evi Regitz, Stephan D. Thome, MD, Henry T. Lynch, MD, Michael Pfreundschuh, MD

Blood (2010) 116 (21): 4085.

https://doi.org/10.1182/blood.V116.21.4085.4085

Published: 2010

Journal Articles

Randomised Intergroup Trial of First line Treatment for young Low-Risk Patients (<61 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL) with a CHOP-like Regimen with or without the Anti-CD20 Antibody Rituximab – 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group

Blood (2010) 116 (21): 111.

https://doi.org/10.1182/blood.V116.21.111.111

Published: 2010

Journal Articles

The Role of the Rituximab Partner Chemotherapy Regimen In Young Patients with Good-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of the 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group.

Niels Murawski, MD, Evelyn Kuhnt, Sandra Grass, MD, Wolfgang Hiddemann, MD, Eva Cavallin-Stahl, MD, Georg Hess, MD, Mathias Witzens-Harig, Ingrid Vasova, MD, Ulrich Jäger, MD, Michal Osowiecki, MD, Scott North, MD, Ruth Pettengell, FRACP, PhD, Viola Pöschel, Markus Löffler, Michael Pfreundschuh, MD

Blood (2010) 116 (21): 2826.

https://doi.org/10.1182/blood.V116.21.2826.2826

Published: 2010

Journal Articles

Single Nucleotide Polymorphisms (SNPs) of FCγRIIA and FCγRIIIA in Patients with Diffuse Large B-Cell Lymphoma Have No Impact On Treatment Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP with and without Rituximab: Results From the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymhoma Study Group (DSHNHL).

Manfred Ahlgrimm, Evi Regitz, Klaus-Dieter Preuss, Sandra Grass, Viola Poeschel, Markus Kreuz, Michael Pfreundschuh

Blood (2009) 114 (22): 3956.

https://doi.org/10.1182/blood.V114.22.3956.3956

Published: 2009

Journal Articles

Male Sex Is Associated with Lower Rituximab Trough Serum Levels and Evolves as a Significant Prognostic Factor in Elderly Patients with DLBCL Treated with R-CHOP: Results From 4 Prospective Trials of the German High-Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, Viola Poeschel, Marcel Reiser, Anthony D. Ho, Christina Nickenig, Swen Wessendorf, Bernd Metzner, Sandra Grass, Joerg Schubert, Markus Loeffler, Norbert Schmitz

Blood (2009) 114 (22): 3715.

https://doi.org/10.1182/blood.V114.22.3715.3715

Published: 2009

Journal Articles

Hyperphosphorylated Paratarg-7 Is a Frequent Antigenic Target of IgM Paraproteins, Is Dominantly Inherited and Represents a Highly Significant Risk Factor for Monoclonal Gammopathy of Undetermined Significance of the IgM Type (IgM-MGUS) and Waldenstrom's Macroglobulinemia (WM), Allowing for the Identification of Family Members at Risk in Cases of Familial IgM-MGUS and WM.

Sandra Grass, Klaus-Dieter Preuss, Alexandra Wikowicz, Evangelos Terpos, Marita Ziepert, Manfred Ahlgrimm, Natalie Fadle, Evi Regitz, Niels Murawski, Meletios A. Dimopoulos, Steven P. Treon, MD, PhD, Zachary Hunter, Michael Pfreundschuh

Blood (2009) 114 (22): 3935.

https://doi.org/10.1182/blood.V114.22.3935.3935

Published: 2009

NARROW

Genetic Polymorphisms of the RANKL and OPG Genes Associated with Myeloma

New Insights in the Pathogenesis of MGUS, Multiple Myeloma (MM) and Waldenström`s Macroglobulinemia (WM): Chronic Antigenic Stimulation by Autoantigenic Targets of Paraproteins Is Mediated by CD4 + t-Cells

Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A

Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM

Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenström macroglobulinemia

Hyperphosphorylation of Antigenic Targets of Paraproteins In MGUS and Multiple Myeloma (MM) Is a Consistent Finding: Implications for the Pathogenesis of MGUS/MM

The Role of the Rituximab Partner Chemotherapy Regimen In Young Patients with Good-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of the 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group.

Male Sex Is Associated with Lower Rituximab Trough Serum Levels and Evolves as a Significant Prognostic Factor in Elderly Patients with DLBCL Treated with R-CHOP: Results From 4 Prospective Trials of the German High-Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only